Security key
071734107
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC)
CUSIP: 071734107
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 223,601,137
- Total 13F value
- $3,484,209,772
- Share change
- -3,116,376
- Put/Call ratio
- 111%
- SEC-reported price per share
- $15.54
- Number of holders
- 303
- Value change
- -$62,682,863
- Number of buys
- 147
- Number of sells
- 135
- Shares outstanding
- 374,002,024
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
303
Top holders
10
BHC full security history
Ownership snapshot
Full 13F holder table
Bausch Health Companies Inc. SEC filings
Bausch Health Companies Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of BHC - Bausch Health Companies Inc. - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PAULSON & CO. INC.
Disclosed value leader
PAULSON & CO. INC.
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F
Highest disclosed value: $472,596,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
PAULSON & CO. INC. has the largest disclosed position value at $472.6M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PAULSON & CO. INC.'s linked filing trail.
Disclosed position value
Top 5
PAULSON & CO. INC.
$472.6M
FIL Ltd
$335.76M
ValueAct Holdings, L.P.
$327.97M
GLENVIEW CAPITAL MANAGEMENT, LLC
$286.13M
VANGUARD GROUP INC
$168.05M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PAULSON & CO. INC. |
13F
Company
|
—
denominator unverified
|
$472,596,000
25,839,035 shares
|
— | 30 Jun 2020 |
| FIL Ltd |
13F
Company
|
—
denominator unverified
|
$335,758,000
18,350,460 shares
|
— | 30 Jun 2020 |
| ValueAct Holdings, L.P. |
13F
Company
|
—
denominator unverified
|
$327,969,000
17,931,594 shares
|
— | 30 Jun 2020 |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$286,131,000
15,644,128 shares
|
— | 30 Jun 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$168,046,000
9,187,882 shares
|
— | 30 Jun 2020 |
| NORGES BANK |
13F
Company
|
—
denominator unverified
|
$167,886,000
7,260,574 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
303
Shares
223,601,137
Rows available
303
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
290
Q3 2020 holders
303
Holder diff
13
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|